For instance, MEG3, a new type of tumor inhibitor, which is downregulated in bladder cancer, was shown to exhibit a negative correlation with autophagy markers (Atg8/LC3) (Ying et al., 2013). This evidence concerns the gene MAP1LC3A and neoplasm.